Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn's Disease: Apropos of a Case

Mesalazine- (5-aminosalicylic acid-) containing products are a well-known treatment for inflammatory bowel disease, often as first line. Myocarditis is recognized as a very rare possible side effect of this drug treatment. We present a case of mesalazine-induced myopericarditis that was successfully...

Descripción completa

Detalles Bibliográficos
Autores principales: Sorleto, Michele, Dürrwald, Stefanie, Wiemer, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523686/
https://www.ncbi.nlm.nih.gov/pubmed/26266055
http://dx.doi.org/10.1155/2015/728310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523686/
https://www.ncbi.nlm.nih.gov/pubmed/26266055
http://dx.doi.org/10.1155/2015/728310

Ejemplares similares